Published in Medical Letter on the CDC and FDA, July 27th, 2003
An initial offering of GeneChip brand SARS arrays will be distributed at no cost to qualifying researchers through the Pathogen Functional Genomics Resource Center (PFGRC), which is operated by The Institute for Genomic Research (TIGR) - a not-for-profit research institute - under contract with the National Institute for Allergy and Infectious Diseases (NIAID).
The SARS-CoV array program is part of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.